In HCC patients with tumor stage 1, we observed that the trend of the high TOP2A expression was related to a shorter survival time, but the difference was not statistically significant (log-rank P = 0.1, Figure 7(h)). Here, TOP2A is linked to hepatocellular carcinoma.